1 recruiting, 1 unknown. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Recruiting 1, Unknown 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow CAEBV: new trials by email Literature Review of CAEBV trials Research Report on CAEBV
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Golidocitinib Combined With Selinexor for CAEBVD golidocitinib, Selinexor (combination therapy) - Lymphohistiocytosis, EBV | Phase 2 / Phase 3 | Recruiting | Beijing Friendship Hospital | 28 | 2026-01-01 | 2026-01-27 |
| Selinexol Combined With Dexamethasone in the Treatment of CAEBV Selinexol and Dexamethasone - CAEBV | Phase 3 | Unknown | Beijing Friendship Hospital | 6 | 2022-05-01 | 2022-04-26 |
Combined Modality Therapy (1) · Dexamethasone (1) · selinexor (1)
Beijing Friendship Hospital (2)
China (2)